Goddres Pharmaceuticals Private Limited

Goddres Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24232MH2010PTC217851 Incorporated 12 January 2010 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹47.78 Cr
▲ 9% YoY
Net profit · FY 2024
₹1.21 Cr
Net margin 2.5%
EBITDA · FY 2024
₹5.21 Cr
EBITDA margin 10.9%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹95 Lakh
Issued & subscribed
Open charges
₹11.94 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Employees · EPFO
248
Provident fund records

About Goddres Pharmaceuticals Private Limited

Data last updated:

Goddres Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 January 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2010PTC217851. Its GSTIN is 27AADCG6434C1ZV (Maharashtra). The company holds 3 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹95 Lakh. It is led by directors including Gourango Mukherjee (Managing Director) and Sanjay Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹47.78 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.21 Cr (net margin 2.5%) and EBITDA of ₹5.21 Cr (EBITDA margin 10.9%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 5% over five years.

The company has about 248 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹11.94 Cr on record. Court records list 5 cases involving the company, including 4 filed against it; 1 case is pending.

Goddres Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0042506). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website goddres.com.

Company Details of Goddres Pharmaceuticals Private Limited
CIN U24232MH2010PTC217851
Registration Number 217851
Incorporation Date 12 January 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0042506

CIN History of Goddres Pharmaceuticals Private Limited

Goddres Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232BR2010PTC015211. The current CIN is U24232MH2010PTC217851, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232MH2010PTC217851Current
U24232BR2010PTC015211Previous
Key People
Gourango Mukherjee Managing Director Sanjay Kumar Director Dev Kumar Chatterjee Director

Recognitions & Rankings of Goddres Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-19-0042506
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    goddres.com
  • Social Media
    Locked
  • Registered Address
    Unit No.304 Third Floor A Wing Western Edge – II Near Western Express Highway Boriwali (, East), Mumbai, Maharashtra, India – 400066
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Goddres Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Goddres Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Goddres Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Goddres Pharmaceuticals Private Limited

The main business activity of Goddres Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Goddres Pharmaceuticals Private Limited FY 2025 filings available

Goddres Pharmaceuticals Private Limited reported revenue of ₹47.78 Cr (up 9% YoY) for FY 2024.

Revenue · FY 2024
₹47.78 Cr ▲ 9%
Net profit · FY 2024
₹1.21 Cr margin 2.5%
EBITDA · FY 2024
₹5.21 Cr margin 10.9%

Compounded Annual Growth Rate (CAGR) of Goddres Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 11%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 10%
5 years · compounded
▲ 9%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 9% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Goddres Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹5.21 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.21 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Goddres Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin10.9%••••••••••••••••
Net Profit Margin2.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Goddres Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Goddres Pharmaceuticals Private Limited

Goddres Pharmaceuticals has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanjay KumarDirector01 Aug 201214 Years 2 MonthsCurrent
Dev Kumar Chatterjee
Also directs: Goddres Wellness Private Limited
Director17 May 201313 Years 5 MonthsCurrent
Dhirendra DeoDirector05 Feb 201016 Years 8 MonthsCurrent
Rajesh Dewan
Also directs: Iyomac Pharmaceuticals Private Limited, Canvarzys Healthcare Limited, Canvarzys Care Private Limited
Director25 Feb 201610 Years 7 MonthsCurrent
Om Prakash GuptaDirector12 Jan 201016 Years 9 MonthsCurrent
Gourango Mukherjee
Also directs: Goddres Wellness Private Limited
Managing Director05 Feb 201016 Years 8 MonthsCurrent
View all directors

Peer Comparison of Goddres Pharmaceuticals Private Limited

Goddres Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Rhydburg Pharmaceuticals Ltd₹48.17 Cr (FY 2024)••••••••26.0%••••Delhi, India
Edkem Pharmaceuticals Limited₹48.11 Cr (FY 2025)••••••••14.0%••••Ahmedabad, Gujarat, India
Indasi Lifescience Private Limited₹48.01 Cr (FY 2025)••••••••25.0%••••Daman, Daman and Diu, India
R.K. Laboratories Private Limited₹47.96 Cr (FY 2024)••••••••10.0%••••Chandigarh, India
Biddle Sawyer Limited₹47.93 Cr (FY 2025)••••••••-28.0%••••Mumbai, Maharashtra, India
Goddres Pharmaceuticals Private Limited this company₹47.78 Cr (FY 2024)••••••••9.0%••••Mumbai, Maharashtra, India
Vineet Laboratories Private Limited₹47.5 Cr (FY 2010)••••••••34.0%••••Hyderabad, Telangana, India
Mendine Pharmaceuticals Pvt Ltd₹47.44 Cr (FY 2025)••••••••3.0%••••Kolkata, West Bengal, India
Linux Life Sciences Private Limited₹47.4 Cr (FY 2025)••••••••52.0%••••Puducherry, India
Lozen Pharma Private Limited₹47.38 Cr (FY 2025)••••••••0.0%••••Savanur, Karnataka, India
Sanctus Global Formulations Limited₹47.05 Cr (FY 2025)••••••••32.0%••••Chandigarh, India

Peers are the five companies nearest above and the five nearest below Goddres Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Goddres Pharmaceuticals Private Limited

Goddres Pharmaceuticals Private Limited is audited by ABHAY & RAHUL for the financial year 2023.

NameStatusAppointment DateCessation Date
ABHAY & RAHULLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Goddres Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Goddres Pharmaceuticals Private Limited

Open charges
₹11.94 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹11.94 Cr
Latest charge details
DateLenderAmountStatus
29 Aug 2022Others₹24 LakhOpen
18 Jan 2021Others₹69.75 LakhOpen
24 Sep 2012Others₹11 CrOpen

Total charge records: 3 View all charges

MSME Payment Delays by Goddres Pharmaceuticals Private Limited

Goddres Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 16 overdue payments to 13 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 13)

SupplierAmount dueDue sinceReported on
an individual supplier••••••••••••
Ip Express Cargo••••••••••••
Roots Advertising••••••••••••
Shakunthlam Enterprises••••••••••••
Elnova••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at Goddres Pharmaceuticals Private Limited

Goddres Pharmaceuticals Private Limited has a workforce of 248 employees as of Apr 08, 2024.

Employee count
248
Active EPFO establishments
1
Employee growth
-0.8%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Goddres Pharmaceuticals Private Limited

Goddres Pharmaceuticals Private Limited has 11 board changes on record since 2010: 6 appointments and 5 cessations. The latest: Om Prakash Gupta ceased to be Director on 03 Feb 2025.

AGM
Goddres Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Goddres Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Om Prakash Gupta ceased to be Director.
Charges
A charge with Others of Rs. 11.00 Cr registered on 24 Sep 2012 with Charge ID 10377496 was modified on 19 Dec 2024.
Charges
A charge with Others amounted to Rs. 0.24 Cr with Charge ID 100618805 was registered on 29 Aug 2022.
Charges
A charge with Others amounted to Rs. 0.70 Cr with Charge ID 100420925 was registered on 18 Jan 2021.
Appointed
Rajesh Dewan was appointed as Director.
Ceased
Rajesh Dewan ceased to be Director.
Appointed
Dev Kumar Chatterjee was appointed as Director.
Ceased
Dev Kumar Chatterjee ceased to be Director.
Charges
A charge with Others amounted to Rs. 11.00 Cr with Charge ID 10377496 was registered on 24 Sep 2012.
Appointed
Sanjay Kumar was appointed as Director.

6 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Goddres Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Goddres Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Goddres Pharmaceuticals Private Limited

Goddres Pharmaceuticals has 3 GST registrations: 3 active.

Total GSTINs
3
Active
3
GSTINStateStatusRegistered on
27AADCG6434C1ZVMaharashtraActive01 Jul 2017
06AADCG6434C1ZZHaryanaActive01 Jul 2017
10AADCG6434C1ZABiharActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Goddres Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Goddres Pharmaceuticals Private Limited

Goddres Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 January 2010 (16+ years old) and is registered under CIN U24232MH2010PTC217851.

Goddres Pharmaceuticals reported revenue of ₹47.78 Cr for FY 2024 (up 9% YoY).

Goddres Pharmaceuticals has 6 current directors:

Goddres Pharmaceuticals reported a net profit of ₹1.21 Cr (net margin 2.5%) and EBITDA of ₹5.21 Cr (EBITDA margin 10.9%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Goddres Pharmaceuticals is 11% over three years and 5% over five years. In the latest year (FY 2024) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Goddres Pharmaceuticals is 27AADCG6434C1ZV, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 06AADCG6434C1ZZ (Haryana), 10AADCG6434C1ZA (Bihar).

The CIN (Corporate Identification Number) of Goddres Pharmaceuticals is U24232MH2010PTC217851. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Goddres Pharmaceuticals has 5 court cases on record: 4 filed against it. 1 is pending. Most are in the district courts.

Goddres Pharmaceuticals was incorporated on 12 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Goddres Pharmaceuticals by revenue are Rhydburg Pharmaceuticals Ltd, Edkem Pharmaceuticals Limited, Indasi Lifescience Private Limited, R.K. Laboratories Private Limited, Biddle Sawyer Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).

Om Prakash Gupta ceased to be Director on 03 Feb 2025. Rajesh Dewan was appointed as Director on 25 Feb 2016. Rajesh Dewan ceased to be Director on 30 Oct 2014. Goddres Pharmaceuticals has 11 board changes on record in total.

Yes, Goddres Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0042506).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available